A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This double-blind, randomized study will evaluate the efficacy, safety and tolerability of
ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD).